[PDF] Risk of cardiovascular events associated with selective COX-2 inhibitors. | Semantic Scholar
@article{Mukherjee2001RiskOC, title={Risk of cardiovascular events associated with selective COX-2 inhibitors.}, author={Debabrata Mukherjee and Steven E. Nissen and Eric J. Topol}, journal={JAMA}, year={2001}, volume={286 8}, pages={ 954-9 }, url={https://api.semanticscholar.org/CorpusID:1117265} }
The results from VIGOR showed that the relative risk of developing a confirmed adjudicated thrombotic cardiovascular event with rofecoxib treatment compared with naproxen was higher than that in the placebo group of a recent meta-analysis of 23 407 patients in primary prevention trials.